Hypercalcemia Appeared in a Patient with Glucagonoma Treated with Octreotide Acetate Long-acting Release
中国医学科学杂志(英文版)2012年27卷第3期 页码:182-184
• Original Article •|Updated:2024-04-10
|
Share with wechat friends or circle of friends
Export references
Hypercalcemia Appeared in a Patient with Glucagonoma Treated with Octreotide Acetate Long-acting Release
Affiliations:
Department of Endocrinology, Key Laboratory of Endocrinology of the Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing,China,100730
Author bio:
Funds:
DOI:
中图分类号:
网络出版日期:2012-10-08,
纸质出版日期:2012
Accepted:
Scan QR Code
Rui Min, Mei Li, Jiang-feng Mao, 等. Hypercalcemia Appeared in a Patient with Glucagonoma Treated with Octreotide Acetate Long-acting Release[J]. 中国医学科学杂志(英文版), 2012,27(3):182-184.
Rui Min, Mei Li, Jiang-feng Mao, et al. Hypercalcemia Appeared in a Patient with Glucagonoma Treated with Octreotide Acetate Long-acting Release[J]. Chinese medical sciences journal, 2012, 27(3): 182-184.
Rui Min, Mei Li, Jiang-feng Mao, 等. Hypercalcemia Appeared in a Patient with Glucagonoma Treated with Octreotide Acetate Long-acting Release[J]. 中国医学科学杂志(英文版), 2012,27(3):182-184.DOI:
Rui Min, Mei Li, Jiang-feng Mao, et al. Hypercalcemia Appeared in a Patient with Glucagonoma Treated with Octreotide Acetate Long-acting Release[J]. Chinese medical sciences journal, 2012, 27(3): 182-184.DOI:
Hypercalcemia Appeared in a Patient with Glucagonoma Treated with Octreotide Acetate Long-acting Release
PABCREATIC neuroendocrine tumours are uncom- mon neoplasms of the pancreas. They may cause a clinical syndrome due to hormone overproduction. Glucagonoma is a rare kind of pancreatic tumors. Here we report a case of glucagonoma. Hypercalcemia occurred when the patient underwent octreotide acetate long-acting release.
Abstract
PABCREATIC neuroendocrine tumours are uncom- mon neoplasms of the pancreas. They may cause a clinical syndrome due to hormone overproduction. Glucagonoma is a rare kind of pancreatic tumors. Here we report a case of glucagonoma. Hypercalcemia occurred when the patient underwent octreotide acetate long-acting release.